$GAN
GAN Ltd Stock $gan

$gan Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224030983 Filed on August 09, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$37.10M	$35.56M
YoY Change	24.42%	5.34%
Cost Of Revenue	$9.920M	$10.24M
YoY Change	7.36%	8.0%
Gross Profit	$27.18M	$25.32M
YoY Change	32.06%	4.3%
Gross Profit Margin	73.26%	71.19%
Selling, General & Admin	$14.60M	$15.04M
YoY Change	2.42%	-13.35%
% of Gross Profit	53.72%	59.39%
Research & Development	$8.467M	$8.137M
YoY Change	-7.46%	-27.59%
% of Gross Profit	31.15%	32.14%
Depreciation & Amortization	$385.0K	$385.0K
YoY Change	-15.01%	3.77%
% of Gross Profit	1.42%	1.52%
Operating Expenses	$14.60M	$15.04M
YoY Change	2.42%	-13.35%
Operating Profit	$2.132M	$229.0K
YoY Change	-129.74%	-102.67%
Interest Expense	$1.160M	$1.157M
YoY Change	-8.23%	27.85%
% of Operating Profit	54.41%	505.24%
Other Income/Expense, Net		-$27.00K
YoY Change		-99.68%
Pretax Income	$972.0K	-$955.0K
YoY Change	-111.52%	-94.64%
Income Tax	-$1.111M	$776.0K
% Of Pretax Income	-114.3%
Net Earnings	$2.083M	-$1.700M
YoY Change	-125.53%	-90.77%
Net Earnings / Revenue	5.61%	-4.78%
Basic Earnings Per Share	$0.05	-$0.04
Diluted Earnings Per Share	$0.04	-$0.04
COMMON SHARES
Basic Shares Outstanding	45.47M shares	45.39M shares
Diluted Shares Outstanding	48.89M shares	45.39M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$36.48M	$36.86M
YoY Change	-6.94%	-15.04%
Cash & Equivalents	$36.48M	$36.86M
Short-Term Investments
Other Short-Term Assets	$4.225M	$4.461M
YoY Change	3.4%	29.15%
Inventory
Prepaid Expenses	$2.743M	$3.686M
Receivables	$12.04M	$8.847M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$55.48M	$53.86M
YoY Change	-0.51%	-11.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.349M	$3.490M
YoY Change	11.0%	9.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.004M	$5.152M
YoY Change	-3.57%	0.57%
Total Long-Term Assets	$27.14M	$27.33M
YoY Change	-17.48%	-19.75%
TOTAL ASSETS
Total Short-Term Assets	$55.48M	$53.86M
Total Long-Term Assets	$27.14M	$27.33M
Total Assets	$82.63M	$81.19M
YoY Change	-6.8%	-14.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.990M	$6.255M
YoY Change	28.28%	29.91%
Accrued Expenses	$10.34M	$9.941M
YoY Change	-13.1%	-26.09%
Deferred Revenue	$10.11M	$10.20M
YoY Change	6.77%	15.47%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$31.88M	$34.61M
YoY Change	-1.82%	7.25%
LONG-TERM LIABILITIES
Long-Term Debt	$45.71M	$44.50M
YoY Change	11.22%	11.89%
Other Long-Term Liabilities	$5.152M	$5.394M
YoY Change	105.42%	65.82%
Total Long-Term Liabilities	$5.152M	$5.394M
YoY Change	105.42%	65.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$31.88M	$34.61M
Total Long-Term Liabilities	$5.152M	$5.394M
Total Liabilities	$88.38M	$91.34M
YoY Change	2.01%	7.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$313.1M	-$315.2M
YoY Change	4.4%	8.02%
Common Stock	$339.4M	$338.4M
YoY Change	1.08%	1.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.754M	-$10.15M
YoY Change
Total Liabilities & Shareholders Equity	$82.63M	$81.19M
YoY Change	-6.8%	-14.53%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$2.083M	-$1.700M
YoY Change	-125.53%	-90.77%
Depreciation, Depletion And Amortization	$385.0K	$385.0K
YoY Change	-15.01%	3.77%
Cash From Operating Activities	-$771.0K	$1.189M
YoY Change	-66.33%	-57.94%
INVESTING ACTIVITIES
Capital Expenditures	$894.0K	$628.0K
YoY Change	-25.5%	-65.25%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$894.0K	-$628.0K
YoY Change	-25.5%	-65.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-771.0K	1.189M
Cash From Investing Activities	-894.0K	-628.0K
Cash From Financing Activities	0.000	0.000
Net Change In Cash	-1.665M	561.0K
YoY Change	-52.29%	-75.76%
FREE CASH FLOW
Cash From Operating Activities	-$771.0K	$1.189M
Capital Expenditures	$894.0K	$628.0K
Free Cash Flow	-$1.665M	$561.0K
YoY Change	-52.29%	-45.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	19646000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	8946000	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001799332
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	GAN	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt		usd
	GAN	Fair Value Adjustment Related To Synthetic Equity FairValueAdjustmentRelatedToSyntheticEquity		usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	GAN	Rightofuse Asset Obtained In Exchange For New Operating Lease Liability RightofuseAssetObtainedInExchangeForNewOperatingLeaseLiability		usd
	GAN	Contract Asset And Contingent Liability Related To Synthetic Equity ContractAssetAndContingentLiabilityRelatedToSyntheticEquity		usd
CY2024Q2	us-gaap	Other Income OtherIncome		usd
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
	dei	Trading Symbol TradingSymbol	GAN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45472877	shares
CY2023Q4	us-gaap	Cash Cash	38578000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	158000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	244000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11417000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3344000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3202000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	56541000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	8370000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12358000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4340000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5895000	usd
CY2023Q4	us-gaap	Assets Assets	87504000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6971000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7849000	usd
CY2023Q4	GAN	Accrued Content License Fees AccruedContentLicenseFees	4024000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10185000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	804000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6891000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	36724000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3793000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	42189000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3577000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5825000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	92108000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45393951	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45393951	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45071578	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45071578	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	451000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	336552000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-309305000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32302000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4604000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	87504000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68887000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14508000	usd
	GAN	Product And Technology Expense ProductAndTechnologyExpense	20816000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20035000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8444000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	83449000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14562000	usd
	us-gaap	Interest Expense InterestExpense	2621000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-27000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	934000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16249000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	659000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16908000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45390559	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45390559	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44147701	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45262413	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43568197	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43568197	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-18409000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5891000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16908000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	155000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1094000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1121000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18254000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6985000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15787000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4604000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4160000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-767000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	840000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-1000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	230000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-8922000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1731000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-327000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	831000	usd
CY2024Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-10151000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20768000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1501000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	966000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1382000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	4000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	79000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	65000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	24607000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	24607000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-18409000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-18409000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	155000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1621000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1963000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	9939000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	9939000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5891000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16908000	usd
	GAN	Amortization Of Software And Intangible Assets AmortizationOfSoftwareAndIntangibleAssets	2953000	usd
	GAN	Amortization Of Software And Intangible Assets AmortizationOfSoftwareAndIntangibleAssets	7708000	usd
	GAN	Depreciation On Property And Equipment And Finance Lease Rightofuse Assets DepreciationOnPropertyAndEquipmentAndFinanceLeaseRightofuseAssets	801000	usd
	GAN	Depreciation On Property And Equipment And Finance Lease Rightofuse Assets DepreciationOnPropertyAndEquipmentAndFinanceLeaseRightofuseAssets	736000	usd
	GAN	Noncash Interest And Amortization Of Debt Discount And Debt Issuance Costs NoncashInterestAndAmortizationOfDebtDiscountAndDebtIssuanceCosts	2309000	usd
	GAN	Noncash Interest And Amortization Of Debt Discount And Debt Issuance Costs NoncashInterestAndAmortizationOfDebtDiscountAndDebtIssuanceCosts	1564000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1641000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3049000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	9717000	usd
	GAN	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	8784000	usd
	GAN	Deferred Income Tax DeferredIncomeTax	118000	usd
	GAN	Deferred Income Tax DeferredIncomeTax	324000	usd
	GAN	Fair Value Adjustment Related To Synthetic Equity FairValueAdjustmentRelatedToSyntheticEquity	221000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	86000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	149000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-948000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3902000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	397000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-993000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1360000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	360000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-433000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1747000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-628000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1699000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-459000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2191000	usd
	GAN	Increase Decrease In Accrued Content License Fees IncreaseDecreaseInAccruedContentLicenseFees	-434000	usd
	GAN	Increase Decrease In Accrued Content License Fees IncreaseDecreaseInAccruedContentLicenseFees	-308000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	354000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2033000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1409000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1171000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-802000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	930000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	909000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1348000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	933000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1987000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	216000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	305000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	206000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1277000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1355000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3569000	usd
	GAN	Repurchase Of Restricted Shares To Pay Tax Liability RepurchaseOfRestrictedSharesToPayTaxLiability	3000	usd
	GAN	Repurchase Of Restricted Shares To Pay Tax Liability RepurchaseOfRestrictedSharesToPayTaxLiability	-409000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4733000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3143000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	66000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1247000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1274000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1137000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1717000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2533000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38578000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45920000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36861000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43387000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1068000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	37000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	158000	usd
	GAN	Rightofuse Asset Obtained In Exchange For New Operating Lease Liability RightofuseAssetObtainedInExchangeForNewOperatingLeaseLiability	2076000	usd
	GAN	Contract Asset And Contingent Liability Related To Synthetic Equity ContractAssetAndContingentLiabilityRelatedToSyntheticEquity	1143000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_806_eus-gaap--NatureOfOperations_zNbp7rKb7CYf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 </b>— <b><span id="xdx_827_zhW2hXEC3SS4">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GAN Limited (the “Parent,” and with its subsidiaries, collectively the “Company”) is an exempted company limited by shares, incorporated and registered in Bermuda.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is a business-to-business (“B2B”) supplier of a proprietary gaming system, GameSTACK™ (“GameSTACK”), which is used predominately by the U.S. land-based casino industry. For its B2B customers, GameSTACK is a turnkey technology solution for regulated real money internet gambling (“real money iGaming” or “RMiG”), online sports gaming, and virtual simulated gaming (“SIM”). In addition, the Company’s B2B segment offers GAN Sports, an in-house online and retail sports betting technology platform, through internet connected self-service kiosks deployed at casino properties and mobile solutions. The Company is also a business-to-consumer (“B2C”) developer and operator of an online sports betting and casino platform under its “Coolbet” brand, providing international users with access through www.coolbet.com to its sportsbook, casino games and poker products. The Company operates its B2C segment in markets across Northern Europe, Latin America, and Canada.</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 7, 2023, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with SEGA SAMMY CREATION INC., a Japanese corporation (“SEGA SAMMY CREATION”), and Arc Bermuda Limited, a Bermuda exempted company limited by shares and a wholly-owned subsidiary of SEGA SAMMY CREATION (“Merger Sub”), pursuant to which, subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will be merged with and into the Company, with the Company surviving the merger as a wholly-owned subsidiary of SEGA SAMMY CREATION (the “Merger”). SEGA SAMMY CREATION and Merger Sub are affiliates of SEGA SAMMY HOLDINGS, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Merger Agreement, and upon the terms and subject to the conditions thereof, at the effective time of the Merger, and as a result of the Merger (and without any action on the part of SEGA SAMMY CREATION, Merger Sub, the Company or any holder thereof):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each of the Company’s ordinary shares issued immediately prior to the effective time of the Merger (other than shares held by SEGA SAMMY CREATION or Merger Sub, by the Company as a treasury share or by any person who properly asserts dissenters’ rights under Bermuda law) will be converted into the right to receive an amount in cash equal to $<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20231107__us-gaap--TypeOfArrangementAxis__custom--MergerConsiderationMember_zxNsjUzaGcdc" title="Share price">1.97</span> per share, without interest and subject to any applicable tax withholding (the “Merger Consideration”);</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each of the Company’s outstanding restricted shares (whether vested or unvested) at the time of the Merger will become vested in full and non-forfeitable and will be converted into the right to receive the Merger Consideration;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each of the Company’s outstanding restricted share units (whether vested or unvested) at the effective time of the Merger will become vested in full and will be automatically cancelled in exchange for the right to receive a single lump sum cash payment, without interest and subject to any applicable tax withholding, equal to the product of (a) the Merger Consideration and (b) the number of Company ordinary shares subject to such restricted share unit; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each of the Company’s outstanding options to acquire the Company ordinary shares (whether vested or unvested) at the effective time of the Merger will become vested in full and will be automatically cancelled in exchange for the right to receive a single lump sum cash payment, without interest and subject to any applicable tax withholding, equal to the product of (a) the excess, if any, of the Merger Consideration over the exercise price per share of the option and (b) the number of Company ordinary shares issuable upon the exercise in full of such option.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consummation of the Merger is not subject to a financing condition, but is subject to customary closing conditions, including (a) approval by the Company’s shareholders of the Merger Agreement, the Merger and the Statutory Merger Agreement, (b) receipt of applicable antitrust and CFIUS approvals or the expiration of applicable waiting periods, (c) absence of any order or injunction prohibiting the consummation of the Merger and (d) the accuracy of the Company’s representations and warranties contained in the Merger Agreement (subject to certain customary qualifications) and compliance by the Company with its agreements and covenants contained in the Merger Agreement. The closing of the Merger is also predicated upon receipt of approval of the Merger and change in control of the Company by all relevant gaming authorities. The Company anticipates that this will take some time, and that the closing of the Merger may not occur until late 2024 or early 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 13, 2024, the Company held a special general meeting of the shareholders of the Company to consider and vote upon the Merger Agreement, at which meeting the shareholders approved the Merger Agreement. Also, the waiting period under applicable antitrust laws expired on June 6, 2024, and on June 27, 2024, the Company received clearance under CFIUS.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-315200000	usd
CY2024Q2	us-gaap	Cash Cash	36900000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10200000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1700000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5900000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	30000000.0	usd
CY2022Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	27600000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	30000000.0	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	42000000.0	usd
CY2023Q2	GAN	Financial Covenant Requirement Minimum Liquidity FinancialCovenantRequirementMinimumLiquidity	10000000.0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zYCHLicXOtH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_z7a7xuCsYieb">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Due to the inherent uncertainties involved in making estimates, actual results could differ from the original estimates, and may require significant adjustments to these reported balances in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	780000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	392000	usd
	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	1057000	usd
	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	1016000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zahhOlj3ayQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zSkWwRJPm4F9">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of its cash and trade receivables. The Company holds cash deposits in foreign countries, primarily in Northern Europe and Latin America, of approximately $<span id="xdx_903_eus-gaap--Deposits_iI_pn5n6_c20240630__srt--StatementGeographicalAxis__custom--NorthernEuropeAndLatinAmericaMember_zEnTH4Tycv3d" title="Cash deposits">28.8</span> million, which are subject to local banking laws and may bear higher or lower risk than cash deposited in the United States. Cash held in the United States is maintained in a major financial institution in excess of federally insured limits. As part of our cash management processes, the Company performs periodic evaluations of the credit standing of the financial institutions and we have not historically sustained any credit losses from instruments held at these financial institutions. However, during the quarter ended June 30, 2024, the Company determined that there was a credit risk with a certain payment service provider (“PSP”) servicing the B2C segment in the amount of $<span id="xdx_900_eus-gaap--OtherAssets_iI_pn5n6_c20240630_zEqnjhESa13j" title="Other current assets">1.9</span> million which has been classified as other current assets at June 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains an allowance for potential credit losses, but historically has not experienced any significant losses related to individual customers or groups of customers in any particular geographic area.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Other Assets OtherAssets	1900000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	45400000	usd
	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation	the Company expects to satisfy $33.0 million within the next five year period, and the remaining over a ten year period.
CY2024Q2	GAN	Amounts Due To Customers Current AmountsDueToCustomersCurrent	1889000	usd
CY2023Q4	GAN	Amounts Due To Customers Current AmountsDueToCustomersCurrent	1994000	usd
CY2024Q2	GAN	Number Of Third Party Gaming Products Available NumberOfThirdPartyGamingProductsAvailable	7600	integer
CY2024Q2	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	4000000.0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	3600000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10201000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10185000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6399000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7303000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2909000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3144000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3490000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4159000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	385000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	371000	usd
	us-gaap	Depreciation Depreciation	801000	usd
	us-gaap	Depreciation Depreciation	736000	usd
CY2024Q2	GAN	Capitalized Computer Software Gross Excluding Development In Progress CapitalizedComputerSoftwareGrossExcludingDevelopmentInProgress	11689000	usd
CY2023Q4	GAN	Capitalized Computer Software Gross Excluding Development In Progress CapitalizedComputerSoftwareGrossExcludingDevelopmentInProgress	10759000	usd
CY2024Q2	GAN	Capitalized Computer Software In Progress Development CapitalizedComputerSoftwareInProgressDevelopment	126000	usd
CY2023Q4	GAN	Capitalized Computer Software In Progress Development CapitalizedComputerSoftwareInProgressDevelopment	494000	usd
CY2024Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	11815000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	11253000	usd
CY2024Q2	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	4111000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2883000	usd
CY2024Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7704000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	8370000	usd
CY2024Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	697000	usd
CY2023Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	490000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1340000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	976000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	49534000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	38881000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10653000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50812000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	38454000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12358000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	834000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3383000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1614000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6732000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1685000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3182000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2725000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2139000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	908000	usd
CY2024Q2	GAN	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	14000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10653000	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	30000000.0	usd
CY2022Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.095	pure
CY2022Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2026-10-26
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	2400000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	27600000	usd
CY2023Q2	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	7300000	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	8800000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	30000000.0	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	42000000.0	usd
CY2023Q2	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.080	pure
CY2023Q2	GAN	Debt Instrument Interest Rate For Exit Fee DebtInstrumentInterestRateForExitFee	0.025	pure
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3100000	usd
CY2023Q2	GAN	Financial Covenant Requirement Minimum Liquidity FinancialCovenantRequirementMinimumLiquidity	10000000.0	usd
CY2024Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.1022	pure
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	46453000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-1955000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	44498000	usd
CY2024Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1166000	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	913000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	252000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	200000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	2310000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	2307000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	499000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	526000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2680190	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.69
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y5M4D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1877000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.01
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	8012	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.01
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	274841	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	5.15
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2447337	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.66
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M17D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1899000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1786821	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.92
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y3M14D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	986000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.55
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.55
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.70
CY2024Q2	us-gaap	Share Price SharePrice	0.01
CY2023Q2	us-gaap	Share Price SharePrice	0.01
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50	pure
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.04	pure
CY2024Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	160000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	177000	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	343000	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	355000	usd
CY2023Q2	us-gaap	Other Income OtherIncome	-427000	usd
	us-gaap	Other Income OtherIncome	-26000	usd
	us-gaap	Other Income OtherIncome	-9718000	usd
CY2024Q2	GAN	Other Loss OtherLoss	27000	usd
CY2023Q2	GAN	Other Loss OtherLoss	8784000	usd
	GAN	Other Loss OtherLoss	27000	usd
	GAN	Other Loss OtherLoss	8784000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-27000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8358000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	934000	usd
CY2023Q2	GAN	Gains On Extinguishment Of Debt GainsOnExtinguishmentOfDebt	400000	usd
	GAN	Gains On Extinguishment Of Debt GainsOnExtinguishmentOfDebt	9700000	usd
	GAN	Fixed Payment FixedPayment	15000000.0	usd
CY2023Q2	GAN	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	8800000	usd
	GAN	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	8800000	usd
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4128049	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5368251	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4128049	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5368251	shares
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35560000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33758000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66211000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68887000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	9000000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2655000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7873000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2117000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	8946000	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2607000	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2607000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1103000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	263000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1287000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	457000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35560000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33758000	usd
CY2024Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	10244000	usd
CY2023Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	9485000	usd
CY2024Q2	GAN	Segment Contribution SegmentContribution	25316000	usd
CY2023Q2	GAN	Segment Contribution SegmentContribution	24273000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66211000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68887000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	19567000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	19646000	usd
	GAN	Segment Contribution SegmentContribution	46644000	usd
	GAN	Segment Contribution SegmentContribution	49241000	usd
CY2024Q2	GAN	Segment Contribution SegmentContribution	25316000	usd
CY2023Q2	GAN	Segment Contribution SegmentContribution	24273000	usd
	GAN	Segment Contribution SegmentContribution	46644000	usd
	GAN	Segment Contribution SegmentContribution	49241000	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7056000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7324000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13073000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14508000	usd
CY2024Q2	GAN	Product And Technology Expense ProductAndTechnologyExpense	8137000	usd
CY2023Q2	GAN	Product And Technology Expense ProductAndTechnologyExpense	11238000	usd
	GAN	Product And Technology Expense ProductAndTechnologyExpense	17753000	usd
	GAN	Product And Technology Expense ProductAndTechnologyExpense	20816000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7980000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10029000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15139000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20035000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1914000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4243000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3753000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8444000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	1157000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	905000	usd
	us-gaap	Interest Expense InterestExpense	2289000	usd
	us-gaap	Interest Expense InterestExpense	2621000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-27000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8358000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	934000	usd
CY2024Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-955000	usd
CY2023Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-17824000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-5364000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-16249000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35560000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33758000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66211000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68887000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35560000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33758000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66211000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68887000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.813	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.033	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.098	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.041	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	85000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	161000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	181000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	547000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3822000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4340000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	811000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	804000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3041000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3577000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3852000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4381000	usd
CY2024Q2	GAN	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	744000	usd
CY2023Q4	GAN	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	378000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	283000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	151000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	568000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	257000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	568000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1137000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1137000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1137000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	636000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4615000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	762000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3852000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M24D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.090	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.089	pure
	us-gaap	Operating Lease Payments OperatingLeasePayments	573000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	215000	usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	9300000	usd
CY2024Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.00
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.00

Files In Submission

Name	View Source	Status
0001493152-24-030983-index-headers.html	Edgar Link	pending
0001493152-24-030983-index.html	Edgar Link	pending
0001493152-24-030983.txt	Edgar Link	pending
0001493152-24-030983-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
gan-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
gan-20240630_cal.xml	Edgar Link	unprocessable
gan-20240630_def.xml	Edgar Link	unprocessable
gan-20240630_lab.xml	Edgar Link	unprocessable
gan-20240630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GAN
GAN Ltd Stock $gan

2024 Q3 Form 10-Q Financial Statement

#000149315224030983 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GAN GAN Ltd Stock $gan

2024 Q3 Form 10-Q Financial Statement

#000149315224030983 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GAN
GAN Ltd Stock $gan